Content matching 'cell therapy approval'
Logical process designs for stem cell manufacturing: computational support tools for improved cost-effectiveness
Scientists expect to have readouts next year from cell and gene therapy trials that could show that regenerative medicine is finally gaining traction.
Cell therapy weekly: FDA aims to advance gene therapies and T cells reprogrammed without the use of viral vectors
Cell therapy weekly: FDA issues strong warning, diabetes gene therapy shows promise in mice, the Cell and Gene Therapy Catapult unveils new project and Takeda eyes an acquisition
Latest developments compiled from 01 – 31 January 2015
Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial
FDA commissioner issues statement on new policies to ensure proper oversight of stem cell therapies
Cell therapy weekly: Is stem cell transplant survival associated with procedure performance number?
Chronic Achilles tendinosis affects both physically active and inactive individuals accounting for 30 to 50% of all sports injuries and 50% of occupation-related disorders in the United States. The study will include 28 participants with chronic Achilles tendinosis. Study participants will receive ultrasound-guided injections of either RCT-01 or placebo (on a 3:1 treatment-to-placebo ratio) directly into areas of injury within the Achilles tendon. Participants’ overall health and tendinosis will be monitored over a six month period while they undergo post-treatment physiotherapy to help facilitate recovery from their Achilles tendinosis.
Latest developments compiled from 1–30 September 2014